Invitae

Developing a Brand Ahead of an IPO

What we did:
Insights • Brand development and strategy

Challenge

Enabled by the low price of Next Generation Sequencing, Invitae was among the many companies were starting out to disrupt genetic testing. Without much clinical history, they needed a unique and compelling story for their upcoming IPO.

Insight

Most people fear their genome. They believe that secrets are lurking, and exposing those secretes would put them at risk of depression, social bias, or manipulation.

Solution

Redevelop the brand to express the company’s belief that our genetics can have the power to unite us, and a singular promise to serve as the most trusted vault for peoples’ genetic identity and information.

If you’d like more details about this or other case studies, reach out below.